1997

Primary care of the HIV/AIDS patient. [computer file]: Stamford, CT : Appleton & Lange, New Media, c1997- computer laser optical discs : sd., col. ; 4 3/4 in. + 1 guide (21 p.) + 1 poster Unique Identifier : AIDSLINE MED/9712582; Henderson JV; (Producer) This virtual clinic allows the user to experience a hands-on environment and gain a sense of first-hand longitudinal care, along with the long-term physical and emotional impact on individual patients. In just a few hours you follow the progress of the disease in your simulated patient--a process normally
al- Idz : marad naqs al-mana'ah al-muktasab, wa-hiwar hawla ijra' ikhtibar al-dam lil-kashf 'an al-isabah bi-fayrus al-idz.: al-Dawhah, Qatar : [s.n.], 1988 50 p. : ill Unique Identifier : AIDSLINE MED/9709357; 'Abd Allah H'
Women and AIDS. 2nd ed.: [Harare] : Zimbabwe Women's Resource Centre and Network, [1993] 28 p (ZWRCN bibliography ; no. 5) Unique Identifier : AIDSLINE MED/9707950
Strategic plan, 1994-1998 : a time to act, a time to care.: [Lusaka, Zambia] : Zambia National AIDS/STD/TB & Leprosy Programme, [1993?] 35 p Unique Identifier : AIDSLINE MED/9709169
HIV/AIDS and sexual health papers. 14-: London : Health Education Authority, c1993- v Unique Identifier : AIDSLINE MED/9612034
National Conference on AIDS 1993 : theme, the role of Indian medicine in search of a remedy to cure AIDS.: Madras : Conference Secretariat, Indian Medical Practitioners' Co-operative Pharmacy and Stores Ltd., 1993 256 p. : ill Unique Identifier : AIDSLINE MED/9714611; Venkatesan K
Phuying kap wikrittakan et. Phim khrang raek.: Krung Thep : Samnakphim Soithong, 2537 [1994] 222 p. : ill Unique Identifier : AIDSLINE MED/9711397; Mayuri Yuphawan
Guidelines for hospitals for notification of transfusion recipients of possible transfusion-related HIV infection.: Don Mills, Ont. : The Association, 1994 21 p Unique Identifier : AIDSLINE MED/9711466
HIV molecular immunology database. 1995- Group T-10: Los Alamos, N.M. : Theoretical Biology and Biophysics Group T-10, Los Alamos National Laboratory, [1995- v. : ill Unique Identifier : AIDSLINE MED/9611415
La corona di nemesi : sul morire e la cultura della morte nell'epoca dell'AIDS.: Como : Filo, c1995 203 p. : ill Unique Identifier : AIDSLINE MED/9709545; Lorenzini M
HIV/AIDS : aspekty medyczne i spoleczne : materialy z konferencji naukowej uniwersytetow Gdanskiego, Yale i Akademii Medycznej w Gdansku, 23.03, 1993 = HIV/AIDS : social and medical aspects. Wyd. 1.: Gdansk : Wydawn. Uniwersytetu Gdanskiego, 1995 265 p. : ill Rozprawy i monografie) Unique Identifier : AIDSLINE MED/9611448; Kmiecik-Baran K
On the margins : men who have sex with men and HIV in the developing world.: London : Panos, c1996 112 p (Special reports) Unique Identifier : AIDSLINE MED/9710899; McKenna N
Resource manual for providing hospice care to people living with AIDS.: Arlington, Va. : National Hospice Organization, c1996 iv, 109 p Unique Identifier : AIDSLINE MED/9707973
Assistenza ai malati terminali in ospedale e a domicilio : aspetti relazionali, organizzativi, formativi.: Milano, Italy : FrancoAngeli, c1996 175 p (IREF/ricerche ; ISSN 752.2.6) Unique Identifier : AIDSLINE MED/9708045; Ranci Ortigosa E
Cancer, SIDA : la qualite de vie. 1. ed.: Le Plessis-Robinson : Synthelabo groupe, c1996 284 p (Collection Les Empecheurs de penser en rond) Unique Identifier : AIDSLINE MED/9705814; Jasmin C
Infezione da HIV e gravidanza : con una nota sull'epatite C.: Milano : Lauri edizioni, c1996 vii, 127 p. : ill (Collana "Le infezioni in gravidanza") Unique Identifier : AIDSLINE MED/9708020; Ippolito G
Sexual behaviour and AIDS in India.: New Delhi : Vikas Pub. House, 1996 xix, 157 p Unique Identifier : AIDSLINE MED/9706330; Nag M
The demographic impacts of HIV/AIDS perspectives from the world population profile : 1996.: Washington, D.C. : International Programs Center, Population Division, U.S. Bureau of the Census, 1997 ix, 43 p. ; ill (IPC staff paper ; no. 86.) Unique Identifier : AIDSLINE MED/9709182; Stanecki K; Way PO
Abstracts of papers presented at the 1997 meeting on retroviruses : May 20-May 25, 1997.: Cold Spring Harbor, N.Y. : Cold Spring Harbor Laboratory, [1997] lxxvii, 394 p Unique Identifier : AIDSLINE MED/9711823; Hughes SH; Coffin JM
AIDS as an apocalyptic metaphor in North America.: Toronto ; Buffalo : University of Toronto Press, c1997 199 p Unique Identifier : AIDSLINE MED/9710913; Palmer SJ
In changing times : gay men and lesbians encounter HIV/AIDS.: Chicago : University of Chicago Press, c1997 xii, 313 p. : ill Unique Identifier : AIDSLINE MED/9713333; Levine MP; Nardi PM; Gagnon JH
Acquired immune deficiency syndrome : biological, medical, social, and legal issues. 3rd ed.: Upper Saddle River, N.J. : Prentice Hall, 1997 Unique Identifier : AIDSLINE MED/9715822; Stine GJ
Medical management of HIV infection. 1997 ed.: [Baltimore, Md.?] : J.G. Bartlett, c1997 ix, 296 p. : ill. ; Unique Identifier : AIDSLINE MED/9711467; Bartlett JG
Manual of HIV therapeutics.: Philadelphia : Lippincott-Raven, c1997 xv, 254 p. : ill Unique Identifier : AIDSLINE MED/9714772; Powderly WG
Sex at risk : lifetime number of partners, frequency of intercourse, and the low AIDS risk of vaginal intercourse.: New Brunswick, N.J. : Transaction Publishers, c1997 ix, 222 p. : ill Unique Identifier : AIDSLINE MED/9715291; Brody S
Illustrated handbook of respiratory disease in HIV infection.: New York : Parthenon, c1998 Unique Identifier : AIDSLINE MED/9715377; Lipman MC; Gluck TA; Johnson MA
Oxidative stress in cancer, AIDS, and neurodegenerative diseases.: New York : M. Dekker, c1998 xiii, 558 p. : ill (Oxidative stress and disease ; 1) Unique Identifier : AIDSLINE MED/9714866; Montagnier L; Pasquier C; Olivier R
A mental health practitioner's guide to the neuropsychiatric aspects of HIV/AIDS.: New York : Guilford Press, c1998 Unique Identifier : AIDSLINE MED/9715676; Van Gorp WG; Buckingham SL
Cardiology in AIDS.: New York : Chapman & Hall, c1998 Unique Identifier : AIDSLINE MED/9715590; Lipshultz SE
HIV and the pathogenesis of AIDS. 2nd ed.: Washington, D.C. : ASM Press, c1998 Unique Identifier : AIDSLINE MED/9716299; Levy JA
What works. AIDS application enhances case managers' productivity and proactivity.: Health Manag Technol. 1997 Aug;18(9):27. Unique Identifier : AIDSLINE MED/97456042; Milakovich P; AIDS Resource Center of Wisconsin, Milwaukee 53202, USA.
Telecare for HIV/AIDS patients.: Caring. 1997 Jul;16(7):42-5. Unique Identifier : AIDSLINE MED/97437922; Kinsella A; Information For Tomorrow, Sunriver, OR, USA.; Telecare--or health care services delivered via telecommunications--can be a valuable adjunct to conventional home care service delivery, particularly to chronic care patients. Technological advances have made it possible for providers to deliver cost-effective telecare to the in-home HIV/AIDS patient.
A note on co-ordinating the AIDS crisis: issues for policy management and research.: Int J Health Plann Manage. 1997 Apr-Jun;12(2):149-57. Unique Identifier : AIDSLINE MED/97459503; Anand P; Templeton College, Oxford, UK.
Charges and charge coverage in the treatment of HIV/AIDS patients in a rural southern state.: J Health Soc Policy. 1997;9(1):77-82. Unique Identifier : AIDSLINE MED/97439351; Strahan ND; Gandy MJ; Mississippi State Department of Health, Jackson 39215, USA.; In Mississippi it was not known where Human Immunodeficiency Virus (HIV) or Acquired Immunodeficiency Disease Syndrome (AIDS) persons receive care, what type of care is available to them, and how care is financed. To ascertain inpatient treatment charges of HIV/AIDS patients, a medical record review was conducted at 1
EMS and HIV: understanding the CDC's provisional guidelines for HIV post-exposure prophylaxis.: Emerg Med Serv. 1997 Jul;26(7):44-6, 63, 67. Unique Identifier : AIDSLINE MED/97456020; West K; Infection control/emerging concepts, Springfield, VA, USA.
The role of computed tomography in community-acquired pneumonia.: Adm Radiol J. 1997 Jun-Jul;16(6-7):30-3. Unique Identifier : AIDSLINE MED/97456011; Hofmann LV; Beall DP; Department of Radiology and Radiological Sciences, Johns Hopkins; Hospital, Baltimore, MD, USA.
Hepatitis C. New guidelines on precautions, follow-up.: OR Manager. 1997 Sep;13(9):38-9. Unique Identifier : AIDSLINE MED/97456124; An OR team has a greater chance of operating on a patient infected with hepatitis C than on a patient with HIV or hepatitis B. Many patients with HCV aren t critically ill, and the team may not know a patient is infected. HCV is more common than many think--an estimated 3.5 million people in the US are infected. The c
Impact of a longitudinal community HIV intervention targeting injecting drug users' stage of change for condom and bleach use.: Am J Health Promot. 1997 Sep-Oct;12(1):15-24. Unique Identifier : AIDSLINE MED/97448548; Jamner MS; Wolitski RJ; Corby NH; Center for Behavioral Research and Services, California State; University, Long Beach, USA.; PURPOSE: To evaluate the impact of the Long Beach AIDS Community Demonstration Project, a community-based HIV-prevention intervention incorporating principles from the Transtheoretical model in its design and evaluation. DESIGN: Repeated cross-sectional sampling with matched intervention and comparison communities. SE
May I ask you a personal question? The right to privacy and HIV testing in the European Community and the United States.: Fordham Law Rev. 1997 May;65(6):2775-824. Unique Identifier : AIDSLINE MED/97623501; Stanley AE
Providers need not disclose HIV status to third parties. Lemon v. Stewart.: J Healthc Risk Manag. 1997 Spring;17(2):45-6. Unique Identifier : AIDSLINE MED/97459518; West JC
European School of Oncology, Second Educational Convention, Vienna, Austria, 1996.: Eur J Cancer; 32A(Suppl 1):S1-S38 1996. Unique Identifier : AIDSLINE MED/97621845; Anonymous; No affiliation given; This supplement consists of the proceedings of the Second Educational Convention of the European School of Oncology held in Vienna, Austria , June 27-29, 1996. Session topic areas were molecular oncology; new drug development; lung cancer; leukemias and lymphomas; breast cancer; ga
Protection against HIV-1 induced apoptosis by inhibition of CPP32beta-related proteases (Meeting abstract).: Proc Annu Meet Am Assoc Cancer Res; 38:A792 1997. Unique Identifier : AIDSLINE MED/97622045; McKenna KA; Dropulic B; Akhtar AJ; Thoburn C; Fuchs EJ; Hess AD; Bedi A; Johns Hopkins Oncology Center, Baltimore, MD 21287; Acquired immunodeficiency syndrome (AIDS) involves the depletion of CD4+ T cells through apoptosis mediated by the Fas surface receptor. Because Fas-induced apoptosis requires activation of the CPP32beta protease, we studied its role in HIV-induced apoptosis. We examined the effect of the HIV-1 Tat protein on apoptosi
The transforming gene product of the t(2;5) translocation of anaplastic large cell lymphoma transactivates the HIV-LTR in CD4+ T-cells (Meeting abstract).: Proc Annu Meet Am Assoc Cancer Res; 38:A948 1997. Unique Identifier : AIDSLINE MED/97622089; Doseeva V; Butscher W; Wellmann A; Stetler-Stevenson M; Gardner K; Laboratory of Pathology, National Cancer Institute, National; Institutes of Health, Bethesda, MD; Anaplastic large cell lymphomas (Ki-1 Lymphoma) are a subclass of human malignant lymphomas with a highly characteristic morphology. These tumors have also been found to occur as an uncommon subtype of AIDS associated lymphomas. Anaplastic large cell lymphoma is associated with a chromosomal translocation [t(2;5)(p23;
Mobilization and collection of peripheral blood progenitor cells PBPC) from AIDS patients (Meeting abstract).: Proc Annu Meet Am Soc Clin Oncol; 16:A157 1997. Unique Identifier : AIDSLINE MED/97622148; Law P; Schwarz L; Looney D; Gervaix A; Young D; Wong-Staal F; Ho AD; Lane TA; University of California, San Diego, CA; Hematopoietic stem cells are ideal vehicles for gene therapy because of their capacities of self-renewal and differentiation into all lineages of mature blood cells. In this study, we evaluated the possibility of mobilizing PBPC in AIDS patients by administration of G-CSF (10 mg/kg/dx6d). Leukapheresis product LP) of
HIV-related non-Hodgkin's lymphoma: centroblastic lymphoma (CL) is associated with better outcome than other histological subtypes (Meeting abstract).: Proc Annu Meet Am Soc Clin Oncol; 16:A161 1997. Unique Identifier : AIDSLINE MED/97622152; Vaccher E; Nasti G; Simonelli C; Santarossa S; Tirelli U; Division of Medical Oncology and AIDS, Aviano Cancer Center, PN),; Italy; HIV-NHL represent an heterogeneous group of diseases, characterized by the presence of distinct molecular-pathological entities, but overall considered associated with a poor outcome. Controversy, however, exists concerning the outcome of CL. In this study we examined the relationship between pathological and clinical
Doxil in patients with pretreated metastatic breast cancer (MBC): a dose-schedule finding study with pharmacokinetics (Meeting abstract).: Proc Annu Meet Am Soc Clin Oncol; 16:A516 1997. Unique Identifier : AIDSLINE MED/97622343; Gabizon A; Uziely B; Lotem M; Yehoshua Z; Tzemach D; Nathan S; Ganelin B; Brufman G; Hadassah Hebrew University Medical Center, Jerusalem 91120, Israel; Doxil is a formulation of polyethylene-glycol coated liposomal doxorubicin used for the treatment of AIDS-related Kaposi s sarcoma. The aims of this study were to optimize the dose-schedule of Doxil and examine its pharmacokinetics in patients (pts) with MBC and previous chemotherapy. Four dose-schedules were investig
The possible role of soluble IL-6R in growth of AIDS-Kaposi's sarcoma cells (Meeting abstract).: Proc Annu Meet Am Assoc Cancer Res; 38:A791 1997. Unique Identifier : AIDSLINE MED/97622044; Murakami-Mori K; Mori S; Taga T; Kishimoto T; Nakamura S; Huntington Memorial Hospital, Pasadena, CA 91105; Kaposi s sarcoma (KS) is most frequently associated with HIV-infected individuals. We found that the soluble IL-6R binding subunit (sIL-6Ralpha) functions as a potent growth factor for AIDS-KS cells, while IL-6 alone has no effect on KS cell growth. KS cells express considerable amounts of the signal transducing subun
Interleukin-12 (IL-12) secretion in Hodgkin's disease (HD) Meeting abstract).: Proc Annu Meet Am Soc Clin Oncol; 16:A138 1997. Unique Identifier : AIDSLINE MED/97622129; Viviani S; Notti P; Bonfante V; Camerini E; Santoro A; Ravagnani F; Pellegris G; Valagussa P; Bonadonna G; Istituto Nazionale Tumori, Milan, Italy; Recently, it has been suggested that cancer-related immunosuppression may depend at least in part on a Th1/Th2 cytokine imbalance, consisting of a decreased Th1-like, and increased type-2 cytokine secretion (Clerici M, J Natl Cancer Inst; 88:461 1996). In particular, IL-2
Evidence of activity of vinorelbine (VNR) in patients (pts) with previously treated epidemic Kaposi's sarcoma (KS) (Meeting abstract).: Proc Annu Meet Am Soc Clin Oncol; 16:A146 1997. Unique Identifier : AIDSLINE MED/97622137; Errante D; Spina M; Tavio M; Vaccher E; Landonio G; Pagani L; Bottura P; Fasan M; Tirelli U; For the Italian Cooperative Group on AIDS and Tumors (GICAT), C.R.O.; Aviano, Italy; VNR is a new semisynthetic vinca alkaloid that seems to disorganize microtubules of the mitotic figure at a lower concentration than other vinca alkaloids. Moreover it does not affect the axonal microtubules. Vinca alkaloids are active agents in the treatment of KS and form the basis for combination regimens, but ther
Palliation of AIDS-related Kaposi's sarcoma of the head and neck mucosa using radiotherapy with altered fractionation to avoid local toxicity (Meeting abstract).: Proc Annu Meet Am Soc Clin Oncol; 16:A159 1997. Unique Identifier : AIDSLINE MED/97622150; Jagetia R; Kiel KD; Von Roenn J; Dutta S; Northwestern Memorial Hospital and Northwestern University Medical; School, Chicago, IL; AIDS related Kaposi s Sarcoma (KS) frequently involves the oral cavity and can cause pain, difficulty swallowing, altered speech, and obstruction. Radiotherapy (generally 20 Gy in 2 Gy fractions daily) reduces tumor bulk but is frequently associated with severe mucositis, more than observed in non-AIDS patients. We ev
Phase I-II evaluation of Panretin (ALRT1057; LGD1057; AGN192013; 9-cis-retinoic acid) topical gel for AIDS-related cutaneous Kaposi's sarcoma (Meeting abstract).: Proc Annu Meet Am Soc Clin Oncol; 16:A160 1997. Unique Identifier : AIDSLINE MED/97622151; uvic M; Friedman-Kien AE; Miles SA; Looney DJ; Stevens V; Truglia J; Yocum R; University of Texas, Houston, TX; PANRETIN topical gel applied to Kaposi s sarcoma (KS) index lesions 1-4 times daily was evaluated for safety and efficacy in controlled Phase I-II studies. 115 AIDS patients with biopsy-proven KS were enrolled at nine centers. 752 treated index and 264 intrapatient control cutaneous KS lesions were evaluated. The cont
Long awaited HIV treatment guidelines released for public comment. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Crit Path AIDS Proj. 1997 Summer;(No 32):1, 9-14. Unique Identifier : AIDSLINE MED/97702721; The long-awaited AIDS treatment guidelines were published on June 19, replacing the obsolete guidelines written in 1993. The earlier guidelines, written before the development of viral load testing and protease inhibitors , recommended sub-optimal treatment using one
The turning point in the AIDS epidemic: new hope, new choices, but little hard data and lots of unanswered questions.: Crit Path AIDS Proj. 1997 Summer;(No 32):1, 15-8. Unique Identifier : AIDSLINE MED/97702722; Kuromiya K; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Researcher David Ho s paper, published in a British journal in 1995, marked a turning point in the AIDS epidemic. Some of Dr. Ho s revolutionary findings in the pathogenesis of HIV are discussed, including the discovery that HIV does not lie dormant in the body for several years, that it reproduces constantly, and tha
Drug interactions: trials and tribulations and cocktails. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Crit Path AIDS Proj. 1997 Summer;(No 32):4-9. Unique Identifier : AIDSLINE MED/97702723; People being treated for HIV frequently face drug reactions and interactions that can be unpleasant, severe, and unpredictable. Combinations of antiretrovirals and prophylactic medications can cause symptoms that negatively impact quality of life or alter the effectiveness of some of the medications. In addition, peop
Compassionate release in California.: Crit Path AIDS Proj. 1997 Summer;(No 32):20-2. Unique Identifier : AIDSLINE MED/97702724; Greenspan J; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Catholic Charities of the East Bay, HIV/AIDS in Prison Project,; Oakland, CA.; Several States have instituted compassionate release programs to allow terminally ill inmates to be released early. The programs are politically sensitive, and the California program is highlighted. Early release, called recall of sentence under the State penal code, is a lengthy and cumbersome process that has result
PWA prisoner resources. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Crit Path AIDS Proj. 1997 Summer;(No 32):23-4. Unique Identifier : AIDSLINE MED/97702725; The incarcerated population of the United States is the only one with a constitutional right to health care, but most care is substandard. A list of resource agencies is included, with brief descriptions of their audience group. It includes a number of prominent AIDS organizations with
A reportback from the Third National Conference on Women and HIV.: Crit Path AIDS Proj. 1997 Summer;(No 32):25-7. Unique Identifier : AIDSLINE MED/97702726; Russell A; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; AIDS Coalition To Unleash Power Philadelphia, Philadelphia, PA.; The Third National Conference on Women and HIV addressed a number of important issues related to infection rates, treatments, and research specific to women. While overall death rates for infected men decreased 15 percent in 1996, the rate for women increased 3 percent. The men s decrease is widely attributed to poten
Health advisory: high blood sugar and diabetes seen in protease inhibitor users. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Crit Path AIDS Proj. 1997 Summer;(No 32):28. Unique Identifier : AIDSLINE MED/97702727; The Food and Drug Administration ( FDA ) has warned physicians that protease inhibitors may contribute to increased blood sugar or diabetes in HIV-positive patients, and recommends closely monitoring their glucose levels. These events
Medical alert: hemolytic anemia in Crixivan cohort. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Crit Path AIDS Proj. 1997 Summer;(No 32):28-9. Unique Identifier : AIDSLINE MED/97702728; Merck is adding a warning label to indinavir ( Crixivan ) as a result of 20 cases of hemolytic anemia reported among the 140,000 people currently using the drug. The disease causes a pr
DMP 266 study opens at Jefferson. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Crit Path AIDS Proj. 1997 Summer;(No 32):30-1. Unique Identifier : AIDSLINE MED/97702730; Dupont Merck announced that its experimental non-nucleoside reverse transcriptase inhibitor DMP 266 has shown viral load reductions to undetectable levels in eighty percent of study subjects. CD4 counts also increased among the study group. Other studies are underway to study DMP 266 at higher dosages and in combinati
Nelfinavir: fourth protease inhibitor approved. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Crit Path AIDS Proj. 1997 Summer;(No 32):31-2. Unique Identifier : AIDSLINE MED/97702732; The Food and Drug Administration ( FDA ) has granted accelerated approval to nelfinavir in both adult and pediatric formulations. Agouron , the manufacturer, used innovative computerized drug design techniques to discover, design, and refine the nelfi
Philadelphia area AIDS/HIV clinical trials. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Crit Path AIDS Proj. 1997 Summer;(No 32):35-44. Unique Identifier : AIDSLINE MED/97702733; This listing of all currently active clinical trials in the Philadelphia area attempts to be an exhaustive list. Contact information, including web sites and phone numbers, are included for each. Participation in trial is extremely limited, and most trials do not require hospitalization. The purposes of each phase of
Expanded access and patient assistance programs for other experimental drugs from their manufacturers. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Crit Path AIDS Proj. 1997 Summer;(No 32):44-64. Unique Identifier : AIDSLINE MED/97702734; The cost of prescription drugs for AIDS treatment is high, and many people have inadequate insurance to cover them. Several pharmaceutical companies have set up hotlines and patient assistance programs to help people get the drugs. Most programs require a physician to do the actual enrollment of patients into the prog
The buyers' clubs. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Crit Path AIDS Proj. 1997 Summer;(No 32):64-6. Unique Identifier : AIDSLINE MED/97702735; Buyers clubs exist to help people with AIDS obtain substances that are normally unavailable to them for a variety of reasons: the substances are illegal, the drugs are not FDA-approved, or the substances are alternative medicines that are generally unavailable in the United States . Co
Want children? Cum clean.: Posit Aware. 1997 Mar/Apr;8(2):9. Unique Identifier : AIDSLINE MED/97702737; Vazquez E; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Researchers are cautiously optimistic that HIV-positive men with undetectable viral loads may be able to have children with HIV-negative women, without infecting either their partner or their baby. A Spanish study showed that 70 percent of the people transmitting the virus had viral loads greater than 15,000 copies. U
Preparing for the future.: Posit Aware. 1997 Mar/Apr;8(2):10-1. Unique Identifier : AIDSLINE MED/97702738; Cox S; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Several new anti-HIV drugs show great promise in future treatments. Nelfinavir, especially effective in combination with AZT and 3TC , is a new protease inhibitor with fewer and milder
New protease inhibitor for children.: Posit Aware. 1997 Mar/Apr;8(2):11. Unique Identifier : AIDSLINE MED/97702739; Vazquez E; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; At the International Conference held in Vancouver, ritonavir Norvir ) and indinavir (
Thalidomide trial to begin. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Posit Aware. 1997 Mar/Apr;8(2):15. Unique Identifier : AIDSLINE MED/97702741; Celgene Corporation is enrolling 84 patients living with AIDS, including children, in a trial of thalidomide (Synovir). Thalidomide caused severe birth defects decades ago, however, it has been shown to be effective in treating AIDS-related aphthous ulcers and wasting syndrome.
Nelfinavir (Viracept) moves up the ranks.: Posit Aware. 1997 Mar/Apr;8(2):16-7. Unique Identifier : AIDSLINE MED/97702742; Grodeck B; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; The anticipated approval of the protease inhibitor nelfinavir Viracept ) will be good for those patients who cannot tolerate the other drugs in that class. Nelfinavir has milder and fewer side effects, and is effective in
The psychology of compliance.: Posit Aware. 1997 Mar/Apr;8(2):18-20. Unique Identifier : AIDSLINE MED/97702743; Condor B; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Chicago Tribune, Chicago, IL.; There is no single personality trait, psychological condition, socioeconomic factor or stage of disease that can reliably be used to predict drug compliance. Missing doses of protease inhibitors can lead to drug resistance, so complying with a treatment regimen is c
Whole body health.: Posit Aware. 1997 Mar/Apr;8(2):28-35. Unique Identifier : AIDSLINE MED/97702745; Austin E; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Alternative therapies, widely used by Americans, include yoga, relaxation techniques, and herbal medications, as well as less conventional and more experimental treatments. The AIDS Research Center in Seattle is conducting the largest study of alternative therapies. Many alternative therapies are used as complements t
Needle exchange: why don't the feds get the point?: Posit Aware. 1997 Mar/Apr;8(2):36-40. Unique Identifier : AIDSLINE MED/97702746; Beaubien G; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; There is no doubt that needle-exchange programs can reduce the incidence of HIV and other blood-borne diseases, however, the issue remains contentious and controversial in the United States . At least half of all new HIV infections in the United States can be traced to risky injection d
Resources for prisoners.: Posit Aware. 1997 Mar/Apr;8(2):46-9. Unique Identifier : AIDSLINE MED/97702747; Bejlovec R; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Resources for inmates to use to educate themselves on HIV/AIDS are provided. Contact information and a description of the services that are available are detailed for each group, including whether the group accepts collect phone calls. Also included is a listing of journals and newsletters specific to the prison popul
Major pediatric study stopped early: combination treatment better.: AIDS Treat News. 1997 Jul 4;(No 274):5-6. Unique Identifier : AIDSLINE MED/97702751; James JS; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; The National Institute of Allergy and Infectious Diseases (NIAID) stopped a clinical trial (ACTG 300) of more than 600 children because of obvious benefits of the combination of zidovudine AZT ) plus lamivudine (
Saquinavir: major study shows survival benefit in treatment-naive patients.: AIDS Treat News. 1997 Jul 4;(No 274):6. Unique Identifier : AIDSLINE MED/97702752; James JS; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; The largest trial ever on AIDS treatment (3,400 volunteers with little or no prior antiviral treatment) reveals that triple drug treatment using saquinavir plus zidovudine ( AZT ) plus zalcitabine
Internet free speech upheld.: AIDS Treat News. 1997 Jul 4;(No 274):7-8. Unique Identifier : AIDSLINE MED/97702753; James JS; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Now that the U.S. Supreme Court has ruled the key provisions of the Communications Decency Act as unconstitutional, AIDS organizations are freer to publish safer-sex information on the Internet without fear of being prosecuted. More information on the Supreme Court decision can be obtained through the following organi
Pediatric trial of 141W94, Vertex protease inhibitor. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Treat News. 1997 Jul 18;(No 275):3. Unique Identifier : AIDSLINE MED/97702755; A new trial of the experimental protease inhibitor 141W94 VX-478) is being conducted with protease inhibitor-naive patients aged between 6 months and 18 years, and with viral loads of at least 10,000 copies. The trial is testing antiviral effect at 16 weeks and durability at 48 weeks. A phase III study of adult patien
Pediatric 1592 compassionate use program begins. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Treat News. 1997 Jul 18;(No 275):3. Unique Identifier : AIDSLINE MED/97702756; Glaxo Wellcome is running a compassionate use program for pediatric users of its experimental antiretroviral, 1592 1592U89). The program is open to patients 6 months to 14 years old who are at high risk of disease progression or death despite current treatments. Physicians
World wide web AIDS medical information.: AIDS Treat News. 1997 Jul 18;(No 275):4-8. Unique Identifier : AIDSLINE MED/97702757; Tobias TT; James JS; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Current high-quality medical information is becoming more accessible via the Internet. Some of the timely and valuable information is from professional conference reports and research databases such as MEDLINE and AIDSLINE. Other information available in this format includes very current standards of medical care, ful
Of clades and quasispecies: making sense of the HIV population census.: J Int Assoc Physicians AIDS Care. 1997 Jul;3(7):13-25. Unique Identifier : AIDSLINE MED/97702758; Mascolini M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; A great debate over the genetic evolution of HIV is under way. This article examines the many attempts to trace this evolution and includes discussions on how selection may drive HIV s evolution, and the controversy surrounding the effect of virion population and the difficulty in measuring it. Reasons clinicians shou
Focus on fungal infections.: J Int Assoc Physicians AIDS Care. 1997 Jul;3(7):27-32. Unique Identifier : AIDSLINE MED/97702759; MacDougall DS; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; New approaches to the diagnosis, treatment, and prevention of fungal infections were discussed at Focus on Fungal Infections in 1997. This article examines the use of early presumptive treatment for candida fungemia, the cause of and treatment for recurrent vulvovaginal candidiasis, and the treatment and prevention pr
Resistance, recombination, evolution--and chance: an interview with Andrew J. Leigh Brown, PhD. [interview by Mark Mascolini]: J Int Assoc Physicians AIDS Care. 1997 Jul;3(7):34-7. Unique Identifier : AIDSLINE MED/97702760; Brown AJL; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Dr. Andrew J. Leigh Brown, Ph.D. provides his insights on the transmission of drug-resistant virus, the role of chance in viral evolution, how often recombination might influence viral evolution in an individual, and moving from theory to practice in the fight against HIV. Dr. Brown states that no data currently exist
Guidelines shed light on identifying failed regimens. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Aug;12(8):87-8. Unique Identifier : AIDSLINE MED/97702761; The new Federal guidelines for HIV treatment address the issues related to failed drug regimens, whether due to compliance, interruption, or drug interactions. The guidelines also distinguish between changing therapy for drug failure and drug toxicity. Doctors are urged to modify elements of the program if viral loads
Training centers gear up to teach new standards. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Aug;12(8):89-90. Unique Identifier : AIDSLINE MED/97702762; Public health officials have designed a series of training programs to give primary care providers access to information from the new Federal guidelines for HIV treatment, and to insure that physicians receive adequate training to apply the recommended treatment effectively. The new guidelines demonstrate the complexi
New treatment a cure? Moment of truth draws nigh. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Aug;12(8):90-2. Unique Identifier : AIDSLINE MED/97702763; A group of patients who have been treated aggressively has remained clear of HIV infection for two years. Biopsies of their lymph nodes, spinal fluid and semen also indicate that they are free of infection. Theoretically, these patients are cured, and they will soon have treatment terminated to test whether that is tr
Protease inhibitors linked to drop in CMV retinitis. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Aug;12(8):92-4. Unique Identifier : AIDSLINE MED/97702764; Several studies suggest that protease inhibitor therapy is linked with a decrease in cases of cytomegalovirus ( CMV ) retinitis, as high as 50 percent at one institute. CMV retinitis afflicts about 40 percent of AIDS patients,
PCR could help screen patients for CMV treatment. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Aug;12(8):94-5. Unique Identifier : AIDSLINE MED/97702765; Polymerase chain reaction (PCR) testing is an effective and economical means to screen patients at high risk of cytomegalovirus ( CMV ) retinitis. Current guidelines recommend ophthalmological reviews every three or four months
Patients should know principles behind new guidelines. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Aug;12(8):suppl 1-4. Unique Identifier : AIDSLINE MED/97702766; The principles behind the new Federal HIV treatment guidelines are described for patients. The benefits and side effects of the new antiretroviral treatments are described. Testing options, preferred treatments, considerations for changing failing drug regimens, and guidelines for treating pregnant women are also disc
Postexposure prophylaxis for HIV.: AIDS Clin Care. 1997 Aug;9(8):59-61, 66. Unique Identifier : AIDSLINE MED/97702767; Daily JP; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Brigham and Women's Hospital, Boston, MA.; Postexposure prophylaxis represents an advance in the management of percutaneous exposure to HIV in the workplace, but its efficacy in other settings needs further study. Three types of occupational exposure, percutaneous, mucous membrane, skin contact or loss of skin integrity, the postexposure prophylaxis to be used
Pursuing a diagnosis in a Caribbean man.: AIDS Clin Care. 1997 Aug;9(8):62-3. Unique Identifier : AIDSLINE MED/97702768; Gulick RM; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; New York University, Medical Center, New York, NY.; A case study of an HIV-infected Caribbean male with extrapulmonary tuberculosis details his diagnosis, treatment regimens, and follow-up. His presenting symptoms included epigastric pain and fever. Endoscopy and gastric biopsy showed gastritis and helicobacter infection, which were treated symptomatically, and TMP-SMX
CMV trial enrolling.: Posit Aware. 1997 Jul/Aug;8(4):13. Unique Identifier : AIDSLINE MED/97702769; Vazquez E; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; A clinical trial is enrolling HIV patients who are newly diagnosed with cytomegalovirus ( CMV ) retinitis in pill form. The study will compare intravenous ganciclovir (Cyotvene) to ganciclovir prodrug, a chemically altered vers
Is it safe to suck?: Posit Aware. 1997 Jul/Aug;8(4):15. Unique Identifier : AIDSLINE MED/97702771; Vazquez E; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; At a recent HIV workshop held in Chicago, IL, researcher David G. Ostrow discussed the results of four clinical studies on oral sex that yielded a range of conclusions. Of the 548,102 AIDS cases that have been recorded in the United States , between 3 and 17 cases occurred because of or
A growing threat: cancer.: Posit Aware. 1997 Jul/Aug;8(4):21-3. Unique Identifier : AIDSLINE MED/97702772; Altman LK; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Malignant tumors, particularly Kaposi s sarcoma and certain cancers of the lymph system, have been common in AIDS patients since 1981. The array of cancers is broadening and researchers are looking for insight into the increases in frequency. An emerging theory is that most AIDS-related cancers are linked to viral inf
Why the old saquinavir (Invirase) may be bad for your health.: Posit Aware. 1997 Jul/Aug;8(4):28-31. Unique Identifier : AIDSLINE MED/97702774; Vazquez E; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; AIDS activists argue that the original formulation of saquinavir may be damaging to people s health and urge those who are considering using saquinavir to wait until the new version of the drug is available. Saquinavir s manufacturer, Roche Laboratories , is being criticized for aggr
Resistance testing.: Posit Aware. 1997 Jul/Aug;8(4):35-7. Unique Identifier : AIDSLINE MED/97702775; Munk B; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Clinical resistance, phenotypic resistance, genotypic resistance, and drug resistance are a few of the terms used to define resistance. Drug resistance refers to HIV s ability to live and multiply even when it is exposed to a lethal dose of antiviral drugs. Clinical resistance occurs when a patient s HIV disease gets
A new game plan.: Posit Aware. 1997 Jul/Aug;8(4):41-50. Unique Identifier : AIDSLINE MED/97702776; Cox S; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; The Office of AIDS Research (OAR) at the National Institutes of Health (NIH) and the US Public Health Service (PHS) assembled committees to recommend a new standard of treatment for HIV infection. Treatment guides designed in response to the recommendations are provided. The guides include recommendations for viral lo
[The Fourth Retroviruses Conference: good news with precautions]: Sidahora. 1997 Apr/May;:14-7. Unique Identifier : AIDSLINE MED/97702778; Arboleda CH; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Gay Men's Health Crisis, New York, NY.; The Fourth Conference on Retroviruses and Opportunistic Infections was held in Washington, D.C. in January 1997. Topics that were presented at the conference include reduced AIDS mortalities in New York, reduced hospitalizations for opportunistic infections, clinical advances in antiretroviral therapies, and treatment
[New knowledge and new challenges: 4th National Conference on Retroviruses & Opportunistic Infections]: Sidahora. 1997 Apr/May;:18-21. Unique Identifier : AIDSLINE MED/97702779; Agosto M; Ehara R; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; National Minority AIDS Council, Washington, DC.; While complete viral suppression of HIV and the use of new combination therapies are quickly becoming the standard for HIV treatment, many questions about this new knowledge are being raised. The Fourth National Conference on Retroviruses and Opportunistic Infections in 1997 began addressing many of these questions. A
[How to go on vacation with HIV]: Sidahora. 1997 Apr/May;:22-5. Unique Identifier : AIDSLINE MED/97702780; Jensen J; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; People living with HIV must be careful about what they eat, especially while on vacation. Recommendations to ensure a safe and enjoyable trip are provided. Some of the recommendations include getting immunized, carrying preventive drugs, and being selective about ordering meats. Guidelines are given on how to pack foo
[How to reveal to children that they are infected with the HIV virus]: Sidahora. 1997 Apr/May;:26-31. Unique Identifier : AIDSLINE MED/97702781; Lipson M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Harlem Hospital Center, New York, NY.; Revealing to a child his or her positive HIV status is not only a clinical dilemma, it is also an ethical dilemma. Parents question when to tell the child, when the child is mature enough to understand, who should tell the child, and whether not telling would protect the child. A number of situations must be considere
[Straight jacket]: Sidahora. 1997 Apr/May;:39-41. Unique Identifier : AIDSLINE MED/97702782; Vasquez D; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Living with HIV in today s prisons can be devastating. Issues such as lost hope, an uncertain future, inequality, and survival are discussed. A comparison is made between the conditions within prison versus the conditions outside of prison for HIV-infected persons. How these prisoners survive within prison is discusse
[HIV infection and vision problems]: Sidahora. 1997 Jun/Jul;:8-13. Unique Identifier : AIDSLINE MED/97702783; Arboleda CH; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Gay Men's Health Crisis, New York, NY.; Visual manifestations of HIV infection and AIDS can present in a variety of ways. Different types of ocular infections are classified and factors that affect diagnosis and treatment are explained. Complications to the eyelids and anterior and posterior parts of the eye are addressed. Steps to determine the presence of
[More color in life: interview with Jairo Pedraza, an activist living with CMV]]: Sidahora. 1997 Jun/Jul;:14-9. Unique Identifier : AIDSLINE MED/97702784; Pedraza J; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Jairo Pedraza, who is HIV-positive and living with cytomegalovirus ( CMV ), responds to questions on how he has dealt with the disease. Jairo tells how he reacted to learning that he is HIV-positive, and explains the steps that
[Fighting with humor: interview with Enrique Andino, an activist living with CMV]: Sidahora. 1997 Jun/Jul;:20-6. Unique Identifier : AIDSLINE MED/97702785; Andino E; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Enrique Andino, who is HIV-positive and living with cytomegalovirus ( CMV ), discusses his personal experiences of living with the disease. Enrique discusses his CMV symptoms, the types of treatments he used, and the results of
[Detecting changes in your vision] Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Sidahora. 1997 Jun/Jul;:27-8. Unique Identifier : AIDSLINE MED/97702786; Sudden changes in vision, an increase of floating particles in the eye, and blurry vision are signals that it is time to visit an ophthalmologist. Ways to assess central and peripheral vision, such as focusing on a word on paper and moving the paper, are explained. Using this method daily makes it easier to notice vis
[Ocular troubles and HIV/AIDS] Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Sidahora. 1997 Jun/Jul;:29-32. Unique Identifier : AIDSLINE MED/97702787; People living with HIV/AIDS are more prone to ocular conditions due to their weakened immune systems. The symptoms of HIV-related ocular conditions, such as cotton wool spots from cytomegalovirus infections, ocular hemorrhage, Kaposi s sarcoma (KS), keratitis, conjunctivitis, ocula
[Crisis in Puerto Rico - Regulation 87] Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Sidahora. 1997 Jun/Jul;:33. Unique Identifier : AIDSLINE MED/97702788; On February 22, 1997, the Puerto Rico Health Department passed Regulation 87, requiring doctors to disclose all HIV-positive cases to the Health Department. A coalition of gay and lesbian activists and organizations claim that Regulation 87 is an invasion of privacy. The direct
[Crisis in Puerto Rico - Project 325]: Sidahora. 1997 Jun/Jul;:34-5. Unique Identifier : AIDSLINE MED/97702789; Vargas JA; Torres A; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Project 325, a needle-exchange program for injection drug users, began in 1995 in Puerto Rico . Opinions on the successes, failures and contradictions of the project, and ways to fight the ban on the distribution of drug paraphernalia are presented. The similarities of Project 3
[Advances and obstacles in the fight against AIDS in Venezuela]: Sidahora. 1997 Jun/Jul;:41-2. Unique Identifier : AIDSLINE MED/97702790; Moreno-Uribe EA; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Panos Institute, Washington, DC.; It is no secret to the Venezuelan authorities that hundreds of citizens living with HIV/AIDS left the country (mainly to Canada and the United States ) in search of treatment to prolong their lives. People who received treatment got better but were f
[The letters of my AIDS]: Sidahora. 1997 Jun/Jul;:47. Unique Identifier : AIDSLINE MED/97702792; Gutierrez J; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; On March 15, 1997, members of the National Organization of Latino Gays and Lesbians (LLEGO) and the HIC Community Coalition (HCC) gathered together to present a program on HIV/AIDS education and prevention. The program brought together various communities in Maryland who are infected or affected by HIV/AIDS. The thoug
Government urges early, aggressive treatment of HIV. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jul 25;12(13):1, 12-3. Unique Identifier : AIDSLINE MED/97702794; June 19, 1997 marked the issuance of clinical guidelines for HIV treatment. The guidelines, issued by a panel convened by the Department of Health and Human Services (HHS) and the Henry J. Kaiser Foundation, recommend treating the infection at an earlier stage and using a three-drug regimen that includes a protease in
Accused stabber need not submit to HIV test, court says. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jul 25;12(13):2. Unique Identifier : AIDSLINE MED/97702795; A Florida Court of Appeals overturned a judge s order directing a woman charged in a stabbing to submit to an HIV test because there was no evidence that the defendant s body fluids touched the victim. The court said the scope of mandatory HIV testing is limited to cases in which the defendant exposes the victim to bo
ADAPs remain in crisis as demand grows for new drugs. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jul 25;12(13):3. Unique Identifier : AIDSLINE MED/97702796; Many State-run AIDS drug assistance programs (ADAPs) remain in perilous financial situations despite an infusion of government funds. Between 1996 and 1997 the amount of money that Federal and State governments spent on the programs rose 85 percent, yet 35 States have had to enact emergency measures within that time f
Illinois court seeks new course in AIDS phobia cases. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jul 25;12(13):4-5. Unique Identifier : AIDSLINE MED/97702798; The Illinois Court of Appeals ruled that plaintiffs cannot be compensated for negligent infliction of emotional distress unless there is a substantial, medically-verifiable possibility of contracting HIV. The new standard will impact a growing body of case law requiring plaintiffs to show that the fear of AIDS was pre
Recent rulings by other courts in AIDS phobia claims. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jul 25;12(13):6-7. Unique Identifier : AIDSLINE MED/97702799; Local, State, and Federal courts have not responded uniformly to fear-of-AIDS claims. The majority of the Supreme and Appeals courts have limited recovery of emotional distress to situations in which the plaintiff was exposed to HIV and faced a realistic prospect of contracting the virus. In California, a shopper who
Court overturns verdict favoring gay lawyer who was fired. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jul 25;12(13):8-9. Unique Identifier : AIDSLINE MED/97702801; The Colorado Supreme Court ruled that a lower court misapplied a smoker s right law meant to stop employers from penalizing workers for legal conduct outside of the office. A new trial has been ordered for Robert P. Borquez, who received a jury award for more than $90,000. Borquez was considered a highly-regarded atto
Report outlines State-run insurance continuity programs. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jul 25;12(13):9. Unique Identifier : AIDSLINE MED/97702802; The National Alliance of State and Territorial AIDS Directors NASTAD) issued a brief that analyzes States responses to health insurance continuity programs for people with HIV. The government makes premium payments for individuals who cannot afford to maintain their existing private health insurance in at least 35 St
Home test kit for HIV fails to capture public's interest. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jul 25;12(13):14. Unique Identifier : AIDSLINE MED/97702804; Direct Access Diagnostics, a subsidiary of Johnson & Johnson , announced on June 26, 1997 that it was discontinuing its Confide kit due to lack of consumer demand. It took nine years for Direct Access Diagnostics to be approved, followed by a legal battle between Johnson & Joh
Court affirms conviction for peddling phony AIDS cure. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jul 25;12(13):15. Unique Identifier : AIDSLINE MED/97702805; In 1996, Charles R. Pixley was convicted on charges of conspiracy and introducing an unapproved drug into interstate commerce and the 2nd U.S. Circuit Court of Appeals upheld the conviction. Pixley s company, Writers and Researchers Inc. sold a drug called 714X to individuals and physicians, promoting it as a nontoxic
Funeral home settles. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jul 25;12(13):16. Unique Identifier : AIDSLINE MED/97702806; Michael s Funeral Home in Schaumburg, ILL settled an AIDS discrimination claim after a judge and a county human rights agency both determined that the survivor in a gay relationship has the legal standing to file an AIDS discrimination complaint. Brian Rabe filed complaints with the Cook County Human Rights Commission
HIV charge dropped. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jul 25;12(13):16. Unique Identifier : AIDSLINE MED/97702807; Guilford County Superior Court Judge James Webb ruled there was not enough evidence to convict HIV-positive Andrew Lee Monk on charges of attempted murder and assault with a deadly weapon in connection with the rape of a 12-year-old girl. Prosecutors argued Monk knew he was HIV-positive when the rape occurred and defe
1592 adult compassionate-use program announced. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Treat News. 1997 Aug 1;(No 276):1. Unique Identifier : AIDSLINE MED/97702808; Few patients will be able to enroll in the newly announced 1592 open-label protocol due to the limited drug supply. To be eligible for this Protocol CNAA/B3008, patients must be over 13 years of age, have a CD4 count lower than 100, and a viral load of at least 30,000 copies within 60 days of registration. Potential p
Federal AIDS policy issues today.: AIDS Treat News. 1997 Aug 1;(No 276):2-8. Unique Identifier : AIDSLINE MED/97702809; James JS; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Congress and the White House are currently grappling with a range of AIDS-related issues, including funding, treatment, and health care access. An outline of the current Federal AIDS issues is provided, including information regarding a significant decline in the AIDS-related death rate, antiviral medications and
3-drug therapy reduces deaths and new AIDS-related illnesses by 50%.: BETA. 1997 Mar;:3-4. Unique Identifier : AIDSLINE MED/97702810; Baker R; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; A 3-drug AIDS treatment trial, ACTG 320, was halted early after it became clinically evident that the therapy was superior to 2-drug combinations in reducing death rates and new AIDS-related illnesses. The study demonstrates the superiority of indinavir
Nelfinavir (Viracept).: BETA. 1997 Mar;:5. Unique Identifier : AIDSLINE MED/97702811; Baker R; Bowers M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; The Food and Drug Administration ( FDA ) is expected to grant accelerated approval for nelfinavir ( Viracept ) by mid-March 1997. Nelfinavir, a potent inhibitor of HIV replication when used in 3-drug therapies with
141 (Vertex-478).: BETA. 1997 Mar;:5. Unique Identifier : AIDSLINE MED/97702812; Baker R; Bowers M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Glaxo Wellcome s (GW) second generation protease inhibitor Vertex-478 (141) is now in Phase II studies. Vertex-478 is being combined with either AZT / 3TC or 1592 (a new nucleoside anal
Ritonavir and ecstasy.: BETA. 1997 Mar;:5. Unique Identifier : AIDSLINE MED/97702813; Baker R; Bowers M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; An overdose death from ecstasy (MDMA) is reported on the Internet. It is believed that the high blood concentration of MDMA in the deceased s body was caused by an interaction with ritonavir , making the liver unable to break down MDMA.
Needle exchange.: BETA. 1997 Mar;:6. Unique Identifier : AIDSLINE MED/97702814; Baker R; Bowers M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Dozens of needle-exchange programs across the country have concluded that needle-exchange programs work, thus leading to the endorsement by the National Academy of Sciences, the Centers for Disease Control and Prevention (CDC), and the General Accounting Office. It is believed that 10,000 lives could have been saved i
Medical marijuana.: BETA. 1997 Mar;:6. Unique Identifier : AIDSLINE MED/97702815; Baker R; Bowers M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Grassroots AIDS activist groups denounce the Clinton Administration s stance on banning medicinal use of marijuana due to the lack of clinical evidence supporting its benefits. The 1997 meeting of the San Francisco Medical Society and the New England Journal of Medicine both agreed, following a review of 75 scientific
Hydroxyurea.: BETA. 1997 Mar;:9-11. Unique Identifier : AIDSLINE MED/97702816; Bowers M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Hydroxyurea, an inhibitor of ribonucleotide reductase in cells, is among the strategies being used to reduce HIV levels. Hydroxyurea disrupts DNA synthesis in rapidly dividing cells and reduces the number of deoxyribonucleotides available to make functional viral products. The combination of hydroxyurea and ddI have s
Psychiatric aspects of HIV.: BETA. 1997 Mar;:12-3, 17. Unique Identifier : AIDSLINE MED/97702817; Romeyn M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Andrew Ziegler Foundation, San Francisco, CA.; HIV-positive men and women have unique psychiatric needs that need to be addressed by medical professionals. Some of the latest developments in the study of psychiatric manifestations of HIV disease are summarized, including an examination of each of the manifestations, the potential for drug interactions, and treatme
Peripheral neuropathy.: BETA. 1997 Mar;:14-7. Unique Identifier : AIDSLINE MED/97702818; Bowers M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; As HIV and AIDS patients live longer, more neurologic disorders are being reported that require prompt identification and treatment. Neuropathies can be caused by nutritional deficiencies, antiretroviral or chemotherapy drugs, certain toxins such as alcohol, and coexistance of other illnesses such as diabetes. Each of
New studies of methods for preventing perinatal HIV transmission.: BETA. 1997 Mar;:20. Unique Identifier : AIDSLINE MED/97702819; Hanna L; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; A number of AIDS clinical trials group studies are investigating the prevention of perinatal HIV transmission (PHT) using triple regimens. Each study generally requires that pregnant women begin prophylactic regimens during the latter part of their pregnancy. Dosing during delivery will involve intravenous infusions o
NIH reaffirms support for perinatal AZT despite cancer findings. National Institutes of Health.: BETA. 1997 Mar;:21. Unique Identifier : AIDSLINE MED/97702820; Highleyman L; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Although two studies have potentially linked cancer in children of HIV-positive women to those who use AZT to prevent perinatal HIV transmission, the National Institutes of Health (NIH) recommends that the current U.S. Public Health Service guidelines
Chemokines and HIV.: BETA. 1997 Mar;:22-7. Unique Identifier : AIDSLINE MED/97702821; Bowers M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Chemokines are being studied to better identify new ways to treat HIV disease, including the development of a vaccine. Chemokine studies have suggested that a cell antiviral factor, a soluble factor secreted by CD8 cells that appears to slow or halt HIV progression in some people, exists. Three chemokines from CD8 cel
Selected highlights from the 4th Conference on Retroviruses and Opportunistic Infections.: BETA. 1997 Mar;:29-38, 41-51. Unique Identifier : AIDSLINE MED/97702822; Bartnof HS; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; San Francisco AIDS Foundation, San Francisco, CA.; The 1997 Fourth Conference on Retroviruses and Opportunistic Infections explored the benefits of newer combination therapies and their effect on HIV in lymphoid tissues, HIV-related drug interactions, HIV therapies that are in the pipeline, chemokine research, and recent insights into HIV/AIDS pathogenesis. Highlights
Open clinical trials for HIV/AIDS treatments.: BETA. 1997 Mar;:52-6. Unique Identifier : AIDSLINE MED/97702823; Hanna L; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; New or changed information is presented concerning the goals and protocols of ongoing HIV/AIDS treatment clinical trials. Clinical trials for treatment of HIV infection, opportunistic infections, malignancies, wasting syndrome, immune enhancement, children and adolescents, and women are highlighted. Also included are
The 1592 controversy.: BETA. 1997 Jun;:6-10. Unique Identifier : AIDSLINE MED/97702824; Baker R; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Activists are urging Glaxo Wellcome to make 1592 ( abacavir ) more readily available in the United States . It is in Phase III trials and there is a compassionate use program
Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. U.S. Department of Health and Human Services (DHHS). Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: BETA. 1997 Jun;:11-22. Unique Identifier : AIDSLINE MED/97702825; The draft Federal guidelines on the use of antiretrovirals in treating adults and adolescents are reprinted. References, panel members names, and some charts and graphs have been left out, ordering information for the full report is included. The guidelines were issues in June 1997 by the U.S. Department of Health an
Nausea and vomiting.: BETA. 1997 Jun;:23-6, 58. Unique Identifier : AIDSLINE MED/97702826; Hanna L; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Nausea and vomiting are frequent, distressing symptoms in HIV and AIDS patients, who are susceptible at any stage of treatment to these debilitating and sometimes life-threatening conditions. A common adverse consequence is that nausea and vomiting can interfere with a patient s ability to follow a prescribed drug reg
Food safety guidelines.: BETA. 1997 Jun;:27, 58. Unique Identifier : AIDSLINE MED/97702827; Hanna L; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Symptoms of nausea, vomiting, and diarrhea to a nonspecific food poisoning can be life-threatening for people with AIDS, particularly for those in the later stages of the disease. Recurrent bouts can lead to additional immune suppression, wasting, and death. Guidelines are provided for insuring that food purchasing an
Diarrhea.: BETA. 1997 Jun;:28-32, 58. Unique Identifier : AIDSLINE MED/97702828; Bowers M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Diarrhea is the greatest single cause of illness and death worldwide, and can be fatal to people with AIDS, 80 percent of whom suffer from diarrhea. There are many causes of diarrhea: bacterial and parasitic infections, opportunistic infections, and contact with contaminated water and food supplies. The physiology of
Selected highlights from the National Conference on Women & HIV, Pasadena, CA, May 4-8, 1997.: BETA. 1997 Jun;:38-45. Unique Identifier : AIDSLINE MED/97702829; Hanna L; Bartnof HS; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Major findings from the National Conference on Women and HIV are presented. Topics include advances in immunology and virology, studies on gender and pain perception, candidiasis in women, chronic endometriosis in acute pelvic inflammatory disease, wasting syndrome, HIV-related cancers, and prevention technologies. Ti
Back to the future: survival, uncertainty, and hope.: Focus. 1997 Jun;12(7):1-4. Unique Identifier : AIDSLINE MED/97702831; Rose A; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Tri-City Health Center, Fremont, CA.; The HIV/AIDS epidemic is compared to the World War II-era Holocaust during which millions of people were persecuted. Those infected and affected by HIV/AIDS are described as undergoing a form of post-traumatic stress disorder. People who provide physical, social, and mental health care services to HIV/AIDS clients are
Clearinghouse: hope and uncertainty. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Focus. 1997 Jun;12(7):4-5. Unique Identifier : AIDSLINE MED/97702832; The field of post-traumatic stress syndrome, as it relates to disease survival and HIV/AIDS, is the subject of books, papers, and research. This reference section lists material related to patient outlook and despair, living with uncertainty, loss and grief, and survival mechanisms. Research contacts in Fremont, CA an
A history of hope: the HIV roller coaster.: Focus. 1997 Jun;12(7):5-7. Unique Identifier : AIDSLINE MED/97702833; Shernoff M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Hunter College, School of Social Work, New York, NY.; The introduction of combination therapies has changed HIV/AIDS from a terminal illness to a chronic manageable condition. The evolution of hope and hopelessness in the HIV/AIDS arena is tracked and related to the current treatment paradigm. Hope is often the essential element for patients coping with a diagnosis of HI
Florida court rejects assisted suicide for AIDS patient. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 8;12(14):1, 5. Unique Identifier : AIDSLINE MED/97702837; A 5-1 Florida Supreme Court ruling reversed a circuit court judge s decision granting a man with AIDS the right to physician-assisted suicide. There are no further options left for Charles E. Hall, who had sought the judge s permission in January 1997 to have his doctor administer a lethal dose of painkillers. In June
New Jersey allows lawsuits based on reasonable fear of HIV. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 8;12(14):1, 10-1. Unique Identifier : AIDSLINE MED/97702838; The New Jersey Supreme Court ruled that a fear of HIV transmission lawsuit may proceed even though no actual exposure occurred. The court added that the suit may be brought only if the fear is justified by state of the art knowledge about the mechanisms of HIV transmission. Most State supreme courts that have consider
Court grants pianist's ex-partner chance to amend suit. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 8;12(14):2. Unique Identifier : AIDSLINE MED/97702839; The Texas Court of Appeals issued rulings in favor of the renowned pianist, Van Cliburn, in the breach-of-contract suit brought against him by his ex-domestic partner, Thomas E. Zaremba. Zaremba alleged that he and Cliburn had an unwritten understanding that they could share Cliburn s income in exchange for the manage
Supreme Court strikes down Montana's sodomy law. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 8;12(14):3. Unique Identifier : AIDSLINE MED/97702840; The Montana Supreme Court struck down the State s sodomy law and ruled that the law violates the State constitutional right to privacy. Until this ruling, all homosexual relations were labeled deviate sexual conduct, punishable by a $50,000 fine and 10 years in prison. No one had been prosecuted under the law since it
Two States sanction needle-exchange programs. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 8;12(14):4. Unique Identifier : AIDSLINE MED/97702841; The Maine and New Hampshire State legislatures authorized the regulation of needle-exchange programs. In Maine, the State Bureau of Health will regulate the distribution, tracking, and disposal of hypodermic needles. The measure is designed to prevent HIV transmission. In New Hampshire, a two-year pilot program within
Most parents are hesitant to tell school about child's HIV. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 8;12(14):4. Unique Identifier : AIDSLINE MED/97702842; The results of a study conducted by researchers at the Massachusetts Department of Public Health indicate that 53 percent of families did not inform schools about a child s HIV status. Among children between the ages of 5 and 10, two-thirds had not been told that they were HIV-positive. Although 99 percent of all chil
Appeals panel reverses ruling favoring life insurer. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 8;12(14):5. Unique Identifier : AIDSLINE MED/97702843; A three-judge panel of the 9th U.S. Circuit Court of Appeals reversed a ruling that favored the Minnesota Mutual Life Insurance Company. The court reinstated a lawsuit brought by the estate of an HIV-positive policy holder, Paul Preston. The suit demands that the insurance company honor a life insurance policy issued
No evidence of impairment, no reduction in sentence. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 8;12(14):11. Unique Identifier : AIDSLINE MED/97702845; The 1st U.S. Circuit Court of Appeals rejected an appeal brought by HIV-positive prison inmate Jose Ivan Montanez-Anaya, who argued that his defense counsel rendered ineffective assistance at trial. Montanez-Anaya bases this claim on the fact that his defense counsel did not invoke Section 5H1.4, a compassionate Feder
Charges dropped. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 8;12(14):12. Unique Identifier : AIDSLINE MED/97702846; Clortis Roberts took care of Lawrence White, an AIDS patient, and inappropriately used White s money for her own use. White sued Clortis and won a jury verdict in a civil suit in 1994. Roberts will not face felony charges for misappropriation of fiduciary property since White passed away and the only evidence the Stat
Home testing. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 8;12(14):12. Unique Identifier : AIDSLINE MED/97702847; Home Access Health Corporation, manufacturer of the Home Access HIV test kit, conducted a survey to determine whether or not people would purchase HIV test kits if they were placed behind a pharmacy counter. Results indicate that 85 percent of those surveyed would look for the kits if they were placed on store shelves
Protease inhibitors' metabolic side effects: cholesterol, triglycerides, blood sugar, and "Crix belly." Interview with Lisa Capaldini, M.D. [interview by John S. James]: AIDS Treat News. 1997 Aug 15;(No 277):1-4. Unique Identifier : AIDSLINE MED/97702848; Capaldini L; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Dr. Lisa Capaldini, an AIDS physician in San Francisco, discusses her experiences with the use of protease inhibitors and their metabolic side effects on cholesterol, triglycerides, blood sugar, and Crix Belly. The ways that these metabolic effects alter the use of
San Francisco: changes at Conant Medical Group. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Treat News. 1997 Aug 15;(No 277):5. Unique Identifier : AIDSLINE MED/97702849; San Francisco s Conant Medical Group was disbanded due to a series of disputes primarily from medical organizations. This closure highlights the need for more public and professional attention to managed care and other issues in medicine today. Because of capitation, physicians treating HIV and/or cancer patients are
Consensus letter: Peter Duesberg.: AIDS Treat News. 1997 Aug 15;(No 277):6-8. Unique Identifier : AIDSLINE MED/97702850; James JS; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Project Inform is circulating a consensus letter concerning Peter Duesberg s campaign to convince the public that HIV is harmless and that accepted medical treatments are useless. The concerns about Duesberg s teachings are being used to justify rejecting all medical care for HIV infection, and ignoring guidelines for
One lump or two.: Notes Undergr. 1997 Jun/Jul;(No 35):1, 7. Unique Identifier : AIDSLINE MED/97702851; Low H; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; The Food and Drug Administration ( FDA ) is warning physicians that their patients who are taking any of the four protease inhibitors are at increased risk for developing hyperglycemia or diabetes. Diabetes and hyperglycemia are serio
1592 - where are you? Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Notes Undergr. 1997 Jun/Jul;(No 35):1. Unique Identifier : AIDSLINE MED/97702852; Relatively small-scale clinical trials of Glaxo Wellcome s new drug 1592 ( abacavir ) will be introduced to 2,500-5,000 patients worldwide in the near future. The drug will also be made available for children. To qualify, patients must have less than 10
Whatever happened to expanded access? Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Notes Undergr. 1997 Jun/Jul;(No 35):2-3. Unique Identifier : AIDSLINE MED/97702853; People living with AIDS (PWAs) have dramatically changed the way new pharmaceuticals are introduced and researched in the United States . Expanded access is the general term for pharmaceutical company programs that distribute new drugs prior to formal approval from the Food and Drug Adm
My first major choice--hope or hype? (a conversation with myself).: Notes Undergr. 1997 Jun/Jul;(No 35):4-7. Unique Identifier : AIDSLINE MED/97702854; Niedzolkowski M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; A question and answer format is presented to provide information about the efficacy of protease inhibitors in the treatment of HIV/AIDS. Patients who qualify and can tolerate these pharmaceutical cocktails have a 60-to-80 percent chance of lowering the amount of vir
The coming sunset on AIDS funding programs. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: PI Perspect. 1997 Jul;(No 22):1-2. Unique Identifier : AIDSLINE MED/97702856; AIDS treatments have entered the long-term, planned strategy phase that could involve many years of therapy, whereas political thinking and the funding that it generates for patient care have not evolved as successfully. Whether or not the patchwork of AIDS funding can be sustained becomes increasingly unclear and les
New Federal guidelines for the use of antiretroviral agents. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: PI Perspect. 1997 Jul;(No 22):3-6. Unique Identifier : AIDSLINE MED/97702857; The U.S. Department of Health and Human Services (DHHS) issued a new set of guidelines for the treatment of HIV disease. The guidelines acknowledge that the pace of HIV disease progression is tightly linked to a patient s individual level of HIV replication. The guidelines suggest that the best treatment is one that s
Update on antivirals. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: PI Perspect. 1997 Jul;(No 22):7-9. Unique Identifier : AIDSLINE MED/97702858; Recent studies are indicating that the standard version of saquinavir is not an appropriate anti-HIV regimen protease inhibitor for beginning therapy. In addition, the new soft gel capsule formulation of saquinavir shows better activity than the available hard gel formulation (HGC), warranting its classification as a
Controlling diarrhea. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: PI Perspect. 1997 Jul;(No 22):9-10. Unique Identifier : AIDSLINE MED/97702859; Diarrhea, a common problem in people living with HIV, has a number of causes and steps to control it. It is important to diagnose the cause(s) of diarrhea as soon as possible, followed by appropriate treatment and replenishment of body fluids. Causes can include diet, lactose intolerance, or the antiviral regimen itse
HIV drug side effects. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: PI Perspect. 1997 Jul;(No 22):10-1. Unique Identifier : AIDSLINE MED/97702860; A guide is provided to help identify the possible causes of side effects when using a particular HIV drug. Side effects and the drugs most commonly used in HIV treatment are both listed. The percentage of people who report each side effect for each drug is given. A contact number is provided for a more extensive versi
HIV neuropathy. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: PI Perspect. 1997 Jul;(No 22):12-3. Unique Identifier : AIDSLINE MED/97702861; Peripheral neuropathy, a potential side effect of many anti-HIV therapies and HIV itself, can adversely affect quality of life. The most effective management of peripheral neuropathy starts with identifying the cause, such as the use of certain HIV drugs, alcohol drin
Hopeful CMV drug stalled. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: PI Perspect. 1997 Jul;(No 22):13. Unique Identifier : AIDSLINE MED/97702862; Although cytomegalovirus ( CMV ) disease, CMV retinitis in particular, is one of the most difficult opportunistic infections to treat, a hopeful new oral form of ganciclovir (proGan) is being stalled. CMV cases have decreased a
Study of GM-CSF enrolling. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: PI Perspect. 1997 Jul;(No 22):14. Unique Identifier : AIDSLINE MED/97702863; A study to determine if GM-CSF (Leukine), in addition to standard therapies, will delay HIV disease progression and death by enhancing immune function is in clinical trials around the United States . Participants can be on any standard anti-HIV and anti-opportunistic infection regimens.
Thalidomide study. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: PI Perspect. 1997 Jul;(No 22):14-5. Unique Identifier : AIDSLINE MED/97702864; Preliminary findings from a study on the effects of thalidomide on HIV-related wasting syndrome are encouraging. The study shows that at least half of the weight gained by participants was in the form of lean body mass. Side effects included declines in neutrophil counts and pain or tingling in the hands and/or feet.
Ethnicity and treatment. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: PI Perspect. 1997 Jul;(No 22):15-6. Unique Identifier : AIDSLINE MED/97702865; CPCRA 007, a study on ethnic/minority groups including African Americans, reveals no significant differences in disease progression, death rates, or the ability of different ethnic groups to tolerate HIV treatments. This contradicts a 1991 study showing that African Americans and Latinos had greater side effects with
Gynecologic conditions and HIV. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: PI Perspect. 1997 Jul;(No 22):18-9. Unique Identifier : AIDSLINE MED/97702867; Studies are reinforcing the need for HIV-infected women to continue getting regular gynecologic examinations so that gynecologic complications can be detected early and monitored regularly. HIV-infected women who also have the human papillomavirus are more likely to progress to cervical cancer than their HIV-negative
Adherence to HAART. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: PI Perspect. 1997 Jul;(No 22):20-3. Unique Identifier : AIDSLINE MED/97702868; The problems of adhering to highly active antiretroviral therapy HAART) are addressed and recommendations on initiating and maintaining therapy regimens are provided. Triple-drug therapy strategies are highlighted, including integrating the regimen into one s life rather than the other way around, counting out medicat
1592 update. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: PI Perspect. 1997 Jul;(No 22):23. Unique Identifier : AIDSLINE MED/97702869; Glaxo Wellcome s 1592 has now been approved for a modest-sized compassionate use program for adults in July 1997 followed by a much larger expanded program in early 1998. Caution is advised. Simply adding 1592 to a failing treatment regimen is not likely to help, and it is less likely to be effective in people who pre
CDC takes a large tiger by the tail: how to handle post-exposure treatment. Centers for Disease Control and Prevention. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Sep;12(9):97-100. Unique Identifier : AIDSLINE MED/97702870; Guidelines for post-exposure prophylaxis (PEP) for occupational exposures and sexual and injection drug use exposures continue to be controversial. Occupational exposures are usually single exposures, whereas sexual and drug use exposures may be the result of repeated exposures. Occupational exposure risk is unavoidab
Experience with PEP finds most patients stop early. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Sep;12(9):101-2. Unique Identifier : AIDSLINE MED/97702872; Intolerance to antiretrovirals is a primary reason for patients to abandon post-exposure prophylaxis (PEP). No Federal guidelines currently exist for PEP in health-care workers, but many hospitals regularly provide early preventive care in cases of occupational exposure. Most hospital-based programs limit the treatmen
Numerical benefits low for non-occupational PEP. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Sep;12(9):102-3. Unique Identifier : AIDSLINE MED/97702873; The costs associated with post-exposure prophylaxis (PEP) for non-occupational HIV exposure would only benefit a relatively low number of people, making it unlikely that wide-scale PEP programs will be initiated. PEP is used now in sexual assault cases where the assailant is known to be HIV-positive or be at high risk
Study shows STDs increase risk of HIV. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Sep;12(9):103-4. Unique Identifier : AIDSLINE MED/97702874; HIV-positive patients receiving antibiotics for other sexually transmitted diseases show lower levels of HIV in their semen, resulting in decreased risk of HIV transmission. An African study confirms that sexually transmitted diseases impact the probability of acquiring and transmitting HIV. Treating sexually transmit
Health officials argue that generalists can treat HIV. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Sep;12(9):104-5. Unique Identifier : AIDSLINE MED/97702875; AIDS experts continue to debate who is most qualified to care for HIV-positive patients: specialists or generalists. The Federal policy is that HIV is a primary care disease and that primary care physicians can adequately prescribe treatments, but many AIDS specialists say that the complexity of treatments means that
Study shows Avanti breaks more than latex condoms. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Sep;12(9):105-7. Unique Identifier : AIDSLINE MED/97702876; The Avanti polyurethane condom had a higher failure rate than latex condoms in a clinical trial, although pregnancy rates were favorable. According to the National Institute of Child Health and Human Development (NICHD) findings, the Avanti condom broke more often than latex control condoms, but pregnancy protection w
Exercise, wellness take on added weight for patients. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Sep;12(9):107-8. Unique Identifier : AIDSLINE MED/97702877; An exercise video for HIV-positive people has been developed by Positive Moves, Inc., an Atlanta non-profit company. New studies show that AIDS patients benefit greatly from wellness and exercise programs. Exercise not only makes patients feel better, but may lead to increases in the immune system as well. Patients pa
Preventive therapy isn't a magic pill for exposures. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Sep;12(9):suppl 1-2. Unique Identifier : AIDSLINE MED/97702878; The risks and costs associated with HIV-related post-exposure treatment make it unlikely that it will become a standard anti-HIV intervention. Exposure types, Federal guidelines for preventive therapy, and potential drawbacks to treatment are outlined.
AIDS web sites face censorship under new rating schemes. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 22;12(15):3. Unique Identifier : AIDSLINE MED/97702881; The American Civil Liberties Union (ACLU) issued a position paper regarding the software industry s proposed rating standards that will block and rate information judged unsuitable for minors. Following the U.S. Supreme Court s overturning of the Communications Decency Act, a ruling that maintains a high level of free
Doctor can't make lab pay damages for false-positive HIV test. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 22;12(15):3. Unique Identifier : AIDSLINE MED/97702882; The Texas Court of Appeals ruled that physician Afsa Meredith was not eligible for damages from a laboratory that misreported HIV test results for one of her patients. Meredith sued Pathlab, Inc., a laboratory that had a policy of performing an ELISA test and a Western blot test, but that only reported the ELISA resul
Guidelines for post-exposure treatment not likely soon. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 22;12(15):4-5. Unique Identifier : AIDSLINE MED/97702883; Post Exposure Treatment (PET) guidelines are being developed by the Centers for Disease Control and Prevention (CDC), but a clear-cut consensus among experts who gathered to develop these guidelines has not been reached. At issue is whether or not PET is effective in cases of rape, unprotected sex, condom leakage, or
Viral DNA test allowed in trial of Louisiana doctor. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 22;12(15):5. Unique Identifier : AIDSLINE MED/97702884; The Louisiana Court of Appeals voted to uphold a decision to allow use of DNA testing in the criminal trial of a physician charged with intentionally injecting his former girlfriend with the blood of an HIV-positive patient. Dr. Richard J. Schmidt of Lafayette will be tried for the attempted murder of Janice Trahan. M
Court sees no basis to void policy issued to man with HIV. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 22;12(15):6-7. Unique Identifier : AIDSLINE MED/97702885; The Massachusetts Supreme Judicial Court found that Protective Life Insurance Company cannot rescind a policy if it failed to detect fraud within a two-year contestability period. The court ruled that the insurer should have exercised reasonable diligence when conducting the medical exam of Dennis J. Sullivan one year
Plaintiff must show a 'channel for infection' to recover damages. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 22;12(15):9. Unique Identifier : AIDSLINE MED/97702887; A spouse of a St. Frances Cabrini Hospital employee has been barred from recovering emotional distress damages for fear of AIDS unless she alleges that there was a channel for infection. Terry Steward sued the Alexandria, LA hospital for negligent infliction of emotional distress after her husband, Cedric Steward, suf
Snafu in Texas prenatal testing to remain on the books. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 22;12(15):10. Unique Identifier : AIDSLINE MED/97702889; The 1997-98 session of the Texas Legislature closed without the passing of several HIV-related bills. In particular, a 1995 law that requires healthcare providers to test pregnant women and provide HIV counseling during prenatal care was allowed to stand. The law is flawed because it requires testing for sexually tran
Driver can't escape alcohol test by claiming AIDS phobia. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 22;12(15):11. Unique Identifier : AIDSLINE MED/97702890; A Pennsylvania appeals court ruled that a suspected drunk driver could not refuse blood alcohol content testing because he feared needles and HIV. The case involves a motorist who refused to take a blood test to determine whether or not he was driving under the influence of alcohol; his license was revoked. The driver
Inmate to remain jailed so he won't sell drugs. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 22;12(15):11. Unique Identifier : AIDSLINE MED/97702891; An HIV-positive defendant sentenced to 60 months in Federal prison for aiding and abetting interstate racketeering was not granted the home confinement that he sought. The 4th U.S. Circuit Court of Appeals refused to overturn the sentencing judge s decision not to initiate compassionate sentencing for defendant Marcus
Confidentiality breach. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 22;12(15):12. Unique Identifier : AIDSLINE MED/97702892; A former Pinellas County, FL public health worker, William B. Calvert III, is charged with using a government AIDS surveillance database for his own personal dating scheme. He kept the county health department records on his own laptop computer and used the information to screen potential dates for himself and his fri
Murders and HIV. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 22;12(15):12. Unique Identifier : AIDSLINE MED/97702893; Investigators have dismissed the previously reported HIV diagnosis links in two prominent homicide cases. Serial murderer Andrew Cunanan, who shot renowned fashion designer Gianni Versace and four other men, was thought to have killed out of rage because his own life was doomed by HIV. Tests conducted during Cunanan s
HIV/AIDS treatment guidelines released.: NIAID AIDS Agenda. 1997 Aug;:1-2, 12. Unique Identifier : AIDSLINE MED/97702894; Randall P; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Guidelines for the use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, a publication created by the U.S. Department of Health and Human Services, have been released after months of anticipation. According to these guidelines, treatment should begin with three antiretroviral agents including one protea
New phase II HIV vaccine study opens.: NIAID AIDS Agenda. 1997 Aug;:3-4. Unique Identifier : AIDSLINE MED/97702895; Doepel LK; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; A new National Institute of Allergy and Infectious Disease NIAID)-sponsored HIV vaccine study will determine if combining two experimental HIV vaccines can stimulate the immune system to fight HIV. The two vaccines, vCP205 and rgp120, are genetically engineered and do not contain HIV; rather, the former contains four
NIAID HIV/AIDS vaccine research. National Institute of Allergy and Infectious Diseases. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: NIAID AIDS Agenda. 1997 Aug;:4. Unique Identifier : AIDSLINE MED/97702896; The status of the National Institute of Allergy and Infectious Diseases (NIAID) HIV/AIDS vaccine research is briefly summarized. To date, seventeen potential HIV vaccines have been tested in humans. In the last two years, HIV vaccine research funding from the National Institutes of Health (NIH) has increased thirty pe
CD4+ T cell diversity not immediately restored by therapy.: NIAID AIDS Agenda. 1997 Aug;:5, 9. Unique Identifier : AIDSLINE MED/97702897; Folkers G; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; One of the arguments for treating early HIV infections lies in the depletion of diverse types of CD4+ T lymphocytes that are not all immediately restored by therapy. The diversity in these cells lies in variations in T-cell receptors that bind to HIV. Variations in the beta chain of the T-cell receptor (V-beta) are of
Gene therapy may restore immune systems.: NIAID AIDS Agenda. 1997 Aug;:8. Unique Identifier : AIDSLINE MED/97702898; Bowersox J; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Researchers are examining an experimental treatment to restore the immune system in HIV-infected persons by using gene therapy based on ribozymes. Ribozymes are forms of RNA that can cleave to other RNA molecules. Cells would be genetically modified to carry anti-HIV ribozymes that could attack HIV RNA when the virus
Combination therapies improve outlook for children with HIV disease. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: NIAID AIDS Agenda. 1997 Aug;:10. Unique Identifier : AIDSLINE MED/97702899; Results of the ACTG 300 clinical trial show that infants and children with symptomatic HIV infection are treated more successfully when given AZT plus either 3TC or ddI, than with ddI
Low-dose oral alpha interferon trial closes. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: NIAID AIDS Agenda. 1997 Aug;:10. Unique Identifier : AIDSLINE MED/97702900; A National Institute of Allergy and Infectious Diseases NIAID)-sponsored trial of low-dose alpha interferon to alleviate symptoms associated with AIDS has been closed due to the lack of direct effect on weight loss and severity of opportunistic infections. One major concern was that patients were choosing to go into t
NIAID evaluates N-9 film as microbicide. National Institute of Allergy and Infectious Diseases. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: NIAID AIDS Agenda. 1997 Aug;:10-1. Unique Identifier : AIDSLINE MED/97702901; Results of a two-year National Institute of Allergy and Infectious Diseases (NIAID)-sponsored study on a nonoxynol-9 spermicide film showed that the agent had no effect on transmission of HIV/AIDS, gonorrhea or chlamydia infections. Female sex workers in Cameroon received instruc
NIAID funds studies of early HIV infection. National Institute of Allergy and Infectious Diseases.: NIAID AIDS Agenda. 1997 Aug;:11. Unique Identifier : AIDSLINE MED/97702902; Parrott C; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Studies on early HIV infection funded by the National Institute of Allergy and Infectious Diseases (NIAID) are reported. Four-year awards were made to researchers at six different institutions to pursue studies on immune functions of cytotoxic T-lymphocytes in HIV infection, distribution of virus between blood and tis
Methadone, adherence and protease inhibitors. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Treat Rev. 1997 Aug;(No 25):2-3. Unique Identifier : AIDSLINE MED/97702903; Protease inhibitors and methadone are both metabolized by the liver, and there is some concern that patients cannot tolerate both treatments simultaneously. Additionally, many question whether methadone patients can even follow the restrictive drug regimen necessary with
Herpes study and resources. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Treat Rev. 1997 Aug;(No 25):5. Unique Identifier : AIDSLINE MED/97702904; Herpes is caused by a virus that causes recurring bouts of cold sores or genital lesions. The differences between herpes simplex virus 1 (HSV-1) and herpes simplex virus 2 (HSV-2) are explained. Herpes outbreaks can become harder to treat when the immune system is damaged by HIV. Ac
Saquinavir update. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Treat Rev. 1997 Aug;(No 25):6. Unique Identifier : AIDSLINE MED/97702905; ACTG 333 tested the effectiveness of other protease inhibitors in patients who had been on saquinavir for two years. Early data showed that neither indinavir (
Stress and therapy study for women. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Treat Rev. 1997 Aug;(No 25):6. Unique Identifier : AIDSLINE MED/97702906; A new study is looking at how non-drug therapies affect quality of life in women with AIDS. Participants will receive either cognitive behavioral stress management (CBSM) or expressive supportive therapy (EST) in group sessions. Participants will be followed for a year, and will receive compensation for being in the s
1592U89 (abacavir) compassionate use. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Treat Rev. 1997 Aug;(No 25):6. Unique Identifier : AIDSLINE MED/97702907; Early studies of 1592U89 ( abacavir ), a new nucleoside analog, suggest that it may have the strongest anti-HIV effect of any drug in its class. 1592U89 is now available via two compassionate use programs for adults and children. Study qualifications an
Pill treatment for CMV. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Treat Rev. 1997 Aug;(No 25):7. Unique Identifier : AIDSLINE MED/97702908; Oral ganciclovir is the only approved pill treatment for cytomegalovirus ( CMV ) retinitis. However, it is poorly absorbed by the body, so patients may need to take 12 pills a day for it to be effective. A clinical trial will c
Combo therapy for children and adolescents. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Treat Rev. 1997 Aug;(No 25):7. Unique Identifier : AIDSLINE MED/97702909; A pediatric study showed combination anti-HIV treatment to be effective in children. In a comparison trial of AZT / 3TC to ddI, AZT/3TC reduced the chance of disease progression by 70 p
DHEA for depression. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Treat Rev. 1997 Aug;(No 25):7. Unique Identifier : AIDSLINE MED/97702910; A clinical trial is underway in New York City to examine the effect of DHEA on mood and energy levels in men and women with HIV infection. DHEA is a hormone essential to the production of testosterone. The trial involves giving all participants DHEA for an initial eight weeks. In the second four weeks, participants wi
HMOs and quality care for HIV -- interview with Stephen Becker, M.D. Part 1 of 2. [interview by John S. James]: AIDS Treat News. 1997 Sep 5;(No 278):1-4. Unique Identifier : AIDSLINE MED/97702911; Becker S; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Dr. Steven Becker, an HIV specialist in private practice in San Francisco, offers his appraisal of HIV and HMO quality of care. Becker states that the quality of HMO care is determined by a set of standards called the Health Plan Employer Data and Information Set (HEDIS). If health organizations do not do well with HE
DMP 266 trials recruiting, many cities -- protease inhibitor naive.: AIDS Treat News. 1997 Sep 5;(No 278):5-6. Unique Identifier : AIDSLINE MED/97702912; James JS; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; DMP 266, a non-nucleoside reverse transcriptase inhibitor (NNRTI) in the same general class as nevirapine or delavirdine , is undergoing clinical trials. Potential advantages of DMP 26
Adefovir dipivoxil trials: CD4 100-500, protease inhibitor naive. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Treat News. 1997 Sep 5;(No 278):6. Unique Identifier : AIDSLINE MED/97702913; Two trials for adefovir dipivoxil combined with other antiretroviral treatments, GS-96/411 and GS-97/417, are currently recruiting in cities throughout the United States . Adefovir dipivoxil is taken once daily; it has shown modest activity against HIV; and it is known to be active agai
Virologic failure; managed care; treatment rejectionists; medical research: GLMA Achievement Award. Gay and Lesbian Medical Association.: AIDS Treat News. 1997 Sep 5;(No 278):7-8. Unique Identifier : AIDSLINE MED/97702914; James JS; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Four HIV treatment issues are addressed by John S. James, the author and a recent recipient of the Achievement Award from the Gay and Lesbian Medical Association (GLMA). Issues addressed are: what should be done when viral load rebounds after treatment, whether people with HIV can receive quality care in the age of ca
Substance use and the puzzle of adherence.: Focus. 1997 Aug;12(9):1-4. Unique Identifier : AIDSLINE MED/97702915; Barthwell AG; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Encounter Medical Group, Oak Park, IL.; The issues of HIV resistance and its relation to patient adherence to treatment are discussed. Non-compliance or misuse of combination therapy fears are usually directed at a single group, substance abusers. There are differences in the availability and use of HIV trea
Clearinghouse: drugs and adherence. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Focus. 1997 Aug;12(9):4-5. Unique Identifier : AIDSLINE MED/97702916; A list of twelve references on HIV drug treatment and adherence is provided. A list of four research contacts is also given.
Immunologic pathogenesis of disease.: Natl Conf Women HIV. 1997 May 4-7;:106 (abstract no. 100.1). Unique Identifier : AIDSLINE MED/97927191; Landay AL; Rush Presbyterian-St. Luke's Medical Center, Chicago, IL.; Over the past 10 years, we have gained significant insights in terms of the host immune response to HIV. We now better understand the importance of immunoregulatory molecules cytokines) in modulating the course of HIV disease and in turn have used this information in designing new therapeutic strategies. In addition,
Blood and genital HIV load.: Natl Conf Women HIV. 1997 May 4-7;:106 (abstract no. 100.2). Unique Identifier : AIDSLINE MED/97927192; Kovacs A; University of Southern California Medical Center, Los Angeles, CA.; With the availability of assays to detect HIV RNA in blood and body fluids, HIV-1 RNA levels are utilized in the day to day management of patients. Methods of detection of RNA in plasma and cervical fluid will be presented. The utility of various assays and clinical correlations will be discussed.
Topical microbicides: the pathway to female-controlled HIV prevention strategies.: Natl Conf Women HIV. 1997 May 4-7;:106 (abstract no. 101.1). Unique Identifier : AIDSLINE MED/97927194; Rosenberg ZF; National Institute of Allergy and Infectious Diseases, National; Institutes of Health, Bethesda, MD.; Heterosexual transmission of HIV presently accounts for the vast majority of new HIV infections worldwide. Women who are at greatest risk of acquiring HIV infection often are unable to negotiate condom use, which is under the control of the male sexual partner. Thus, it is urgent that more acceptable, affordable, fema
<